Overview * Sweden healthcare equipment firm's Q2 revenue grew 4.7% organically, beating analyst expectations * Adjusted EBITDA and adjusted EBIT for Q2 both beat analyst expectations * Company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
BRIEF-Iovance Biotherapeutics Reports Inducement Grants
Oct 16 (Reuters) - Iovance Biotherapeutics Inc: * IOVANCE BIOTHERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ…
Judge dismisses indictment of actor Timothy Busfield on child sexual assault
By Lisa Richwine LOS ANGELES, Oct 16 (Reuters) - A judge in New Mexico on…
US tells election officials to be on guard against AI-powered tricks ahead of midterms
WASHINGTON, Oct 16 (Reuters) - The FBI and the US cyber defense agency CISA are…
